General James Mattis (USMC Ret.) was the commander of U.S. Central Command (CENTCOM), retiring in 2013. He joined the board of General Dynamics, the fourth largest contractor for the Department of Defense, five months later. He also joined the board of Theranos, a controversial blood-testing company he advocated for while in the Marine Corps, and was an unpaid military advisor for the United Arab Emirates. He was Secretary of Defense from January 20, 2017 to January 1, 2019. Mattis was re-elected to the board of General Dynamics on August 7, 2019.
As a General Dynamics board member he received almost $1 million in compensation
Commander, Central Command,
U.S. Central Command (CENTCOM)
Board of Directors,